openPR Logo
Press release

Neuromodulation Market to Exceed US$ 11 Billion Globally by 2022

New York, May 03: Market Research Engine has published a new report titled as “Neuromodulation Market By Technology Analysis (Internal neuromodulation, External neuromodulation); By Application Analysis (Chronic Pain Management, Tremor, Failed back syndrome, Epilepsy, Depression, Urinary and Fecal Incontinence, Dystonia, Obsessive-Compulsive Disorder, Gastroparesis, Migraine, Parkinson’s disease); By Biomaterial Analysis (Polymeric Biomaterials, Metallic Biomaterials, Ceramic Biomaterials) and By Regional Analysis – Global Forecast by 2016 – 2022”.

How Big is the Global Neuromodulation Market?

The Global Neuromodulation Market is expected to exceed more than US$ 11 Billion by 2022 and will grow at a CAGR of more than 11% in the given forecast period.

Browse Full Research Report: https://www.marketresearchengine.com/reportdetails/neuromodulation-market-report

Neurological disorders which include epilepsy, alzheimer disorder, cerebrovascular sicknesses, and Parkinson’s disease have an effect on the critical and peripheral anxious machine. Bacterial, viral, and fungal infections also can reason neurological disorders. To manage such problems, neuromodulation is used; in which small electrodes generate electric most precise stimulation with the help of pulse generators to complement neurological activities in effected humans. The electrodes are normally located without delay within the mind or peripheral nerves or spinal twine while pulse mills are implanted within the pores and skin.

The major driving factors of Global Neuromodulation Market are as follows:

• Increase in geriatric population
• Rise in awareness regarding the efficacy and safety of neurostimulator devices.
• Growing incidence of neurological diseases

The restraining factors of Global Neuromodulation Market are as follows:

• Stringent approval policies
• Lack of trained healthcare professionals

The Global Neuromodulation Market is segmented on the lines of its technology, application and biomaterial. Technology segmentation is further classified into internal neuromodulation and external neuromodulation. Based on internal neuromodulation segmentation it covers deep brain stimulation, spinal cord stimulation, vagus nerve stimulation, sacral nerve stimulation and other neuromodulation technologies. External neuromodulation is classified into transcranial magnetic stimulation and transcutaneous electrical nerve stimulation. Based on application segmentation it covers chronic pain management, tremor, failed back syndrome, epilepsy, depression, urinary and fecal incontinence, dystonia, obsessive compulsive, disorder, gastroparesis, migraine, parkinson’s disease and other applications. Under biomaterial segmentation it covers polymeric biomaterials, metallic biomaterials and ceramic biomaterials. The Global Neuromodulation market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

This report provides:

1) An overview of the global market for Global Neuromodulation and related technologies.

2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.

3) Identifications of new market opportunities and targeted promotional plans for Global Neuromodulation Market.

4) Discussion of research and development, and the demand for new products and new applications.

5) Comprehensive company profiles of major players in the industry.

REPORT SCOPE:

The scope of the report includes a detailed study of global and regional markets for Global Neuromodulation Market with the reasons given for variations in the growth of the industry in certain regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Medtronic plc, St. Jude Medical, Inc., LivaNova PLC, Boston Scientific Corporation, Aleva Neurotherapeutics SA, BioControl Medical, Bioness Inc., EnteroMedics Inc., Nevro Corporation and NeuroPace Inc. Company profile includes assign such as company summary, financial summary,business strategy and planning, SWOT analysis and current developments.

The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.

The Global Neuromodulation Market has been segmented as below:

By Technology Analysis

• Internal neuromodulation
o Deep Brain Stimulation
o Spinal Cord Stimulation
o Vagus Nerve Stimulation
o Sacral Nerve Stimulation
o Other Neuromodulation Technologies

• External neuromodulation
o Transcranial Magnetic Stimulation
o Transcutaneous Electrical Nerve Stimulation

By Application Analysis

• Chronic Pain Management
• Tremor
• Failed back syndrome
• Epilepsy
• Depression
• Urinary and Fecal Incontinence
• Dystonia
• Obsessive-Compulsive Disorder
• Gastroparesis
• Migraine
• Parkinson’s disease
• Other Applications

By Biomaterial Analysis

• Polymeric Biomaterials
• Metallic Biomaterials
• Ceramic Biomaterials

By Regional Analysis

• North America
• Europe
• Asia-Pacific
• Rest of the World

Reasons to Buy this Report:

1) Obtain the most up to date information available on all Global Neuromodulation Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Global Neuromodulation Market data.
4) Assess your competitor’s refining portfolio and its evolution.

About MarketResearchEngine

Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.

Media Contact

Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862
Country: United States
Website: https://www.marketresearchengine.com

Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neuromodulation Market to Exceed US$ 11 Billion Globally by 2022 here

News-ID: 522961 • Views: 317

More Releases from Market Research Engine Report

3D Printing Materials Market is Expected to Exceed USD 1400 Million by 2020
The 3 D Printing Materials Market is segmented based on material type, form and application. The 3 D Printing Materials Market is segmented based on material type as Plastics, Metals, Ceramics, Others. The 3 D Printing Materials Market is segmented based on form as Filament, Powder, Liquid. The 3 D Printing Materials Market is segmented based on application as Aerospace & defense, Medical & dental, Automotive, Consumer Goods,
Titanium Dioxide Market is Expected to Reach US$ 21 Billion by 2021
The global titanium dioxide market by application is segmented as paints & coatings, pulp & paper, plastics, cosmetics and other applications. The market segments in terms of geographical regions include North America, Europe, Asia-Pacific and Rest of the World (ROW). Browse Full Report @: https://www.marketresearchengine.com/reportdetails/titanium-dioxide-market How Big is the Global Titanium Dioxide Market? Global titanium dioxide market was accounted USD 15.5 billion in 2015. The revenue of this market is anticipated to increase
IoT Healthcare Market in North America is Expected to Grow at CAGR of 43% by 202 …
The IoT healthcare market is divided into technologies and services. The technologies segment is again analyzed by network technologies and applications technologies. The network technologies are further segmented to short range technologies and long-range technologies which are equally vital top form a connected ecosystem of healthcare. The service market is analyzed by consulting, integration and maintenance. The solution segment contributes to a majority part of the market. Browse Full Report
Nonalcoholic Steatohepatitis (NASH) Market is Expected to Cross US$ 20.0 Billion …
The Nonalcoholic Steatohepatitis market is segmented on the lines of its Therapeutics such as GFT505, Obeticholic Acid (INT-747) Simtuzumab and Liraglutide (Victoza)Vitamin EPioglitazonePlacebo. The Nonalcoholic Steatohepatitis market geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Browse Full Report @: https://www.marketresearchengine.com/reportdetails/non-alcoholic-steatohepatitis-nash-market How Big is the Global Nonalcoholic Steatohepatitis (NASH) Market? Global Non-Alcoholic Steatohepatitis (NASH) market is expected to cross US$ 20.0 Billion by

All 5 Releases